Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Directorate Change

22 May 2015 07:00

RNS Number : 9899N
De La Rue PLC
22 May 2015
 

DE LA RUE PLC

CHANGE OF DIRECTORATE

 

 

De La Rue plc announces that, having served nine years as a Non-executive Director, Gill Rider has advised the Board that she intends to step down at the Company's AGM on 23 July 2015. Dr Rider was appointed as a Non-executive Director of De La Rue plc on 22 June 2006 and is currently Chairman of the Remuneration Committee.

 

The Company is pleased to announce the appointments of Maria Da Cunha and Sabri Challah as Non-executive Directors of the Company with effect from 23 July 2015.

 

Ms Da Cunha is currently Director of People and Legal at British Airways plc, a position she has held since 2011. Ms Da Cunha joined British Airways in 2000 and has extensive experience of people strategy, including culture change, talent management and learning and development, as well as experience in high profile and complex international legal matters and international government and regulatory affairs. She is a member of British Airways' Executive Board.

 

Dr Challah, following a 28 year career with Deloitte, the multinational professional services firm, has significant and wide ranging experience in organisational design, change management, strategy, and corporate development. As a partner at Deloitte between 1991 and 2013, he held a range of positions and served as a Member of both the Global and UK Board (where he was Chairman of the Remuneration Committee). His work for clients across a range of industries includes significant experience in the public sector.

 

Dr Challah will succeed Gill Rider as Chairman of the Remuneration Committee.

 

We are also pleased to announce the appointment of Rupert Middleton, Chief Operating Officer, to the Board as an Executive Director of the Company with effect from 23 July 2015. Mr Middleton joined De La Rue in October 2011 and has extensive experience of manufacturing with a particular emphasis on printing. During his time with De La Rue Mr Middleton has transformed the Manufacturing function through the implementation of an operational excellence programme. Previously he was Group Director of Manufacturing at Trinity Mirror, responsible for the integrated manufacturing division.

 

The new appointments will take effect immediately following the Annual General Meeting of the Company on 23 July 2015.

 

As previously announced, Warren East will step down as a Non-executive Director at the Company's AGM on 23July 2015. Andrew Stevens will succeed Mr East as the Senior Independent Director and Victoria Jarman will succeed Mr East as Chairman of the Audit Committee.

 

Philip Rogerson, Chairman of De La Rue plc said:

 

"On behalf of the Board I would like to thank Gill Rider and Warren East for their wise counsel and invaluable contribution during their time as Non-executive Directors, and their careful stewardship of the Remuneration Committee and Audit Committee respectively. We extend our very best wishes to Gill and Warren for the future.

 

"Maria Da Cunha and Sabri Challah bring highly relevant experience of strategy execution and change management which will enable them to make an excellent contribution to the Board at an exciting time for the business. I look forward to welcoming them to De La Rue. Rupert Middleton has a proven track record of driving productivity, quality and procurement improvements and his expertise will be an important asset to the Board".

 

There is nothing which is required to be disclosed under Listing Rule 9.6.13 in respect of Maria Da Cunha, Sabri Challah or Rupert Middleton.

 

- ends -

 

22 May 2015

 

Enquiries:

 

De La Rue plc +44 (0)1256 605000

Martin Sutherland Chief Executive

Colin Child Group Finance Director

 

Brunswick +44 (0)207 404 5959

Jon Coles

Oliver Hughes

 

Notes to editors:

De La Rue is a leading commercial banknote printer, security paper maker and provider of security products and software solutions and, as a trusted partner of governments, central banks and commercial organisations around the world, is at the forefront of the battle against the counterfeiter.

As the world's largest commercial banknote printer, De La Rue provides customers with a fully integrated range of sophisticated products and services which are available either individually or as a whole. This includes a leading design capability, production of innovative security components, manufacture of security paper and polymer substrates and sophisticated printing of banknotes, all contributing to trust in the integrity of currencies.

De La Rue is the world's largest commercial passport manufacturer in an environment of increasing global concern over security at national boundaries and border control. De La Rue also produces a wide range of other security products, including tax stamps for governments who are seeking to combat illicit trade and collect excise duties. Other products include authentication labels, assuring purchasers of product validity, and government identity documents. In addition the Group manufactures high speed cash sorting and banknote inspection equipment.

The company also provides a range of specialist services and software solutions including government identity schemes, product authentication systems and cash management processing solutions.

De La Rue is listed on the London Stock Exchange (LON:DLAR). For further information visit www.delarue.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUAVBRVWAVUAR
Date   Source Headline
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company
27th Jun 20231:54 pmRNSHolding(s) in Company
26th Jun 20237:00 amRNSDirectorate Change
22nd Jun 20234:43 pmRNSHolding(s) in Company
21st Jun 20233:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSDirectorate Change
12th Jun 20237:00 amRNSDirectorate Change
1st Jun 202310:36 amRNSTotal Voting Rights
23rd May 20234:33 pmRNSHolding(s) in Company
18th May 20237:00 amRNSAppointment of Chairman
9th May 20237:00 amRNSNotice of Results
2nd May 20237:00 amRNSFurther re recruitment of Chairman
18th Apr 20232:52 pmRNSWithdrawal of General Meeting requisition
14th Apr 20234:19 pmRNSResignation of Chairman and accelerated search
12th Apr 20237:00 amRNSTrading update
6th Apr 20237:00 amRNSFurther re appointment of CFO
3rd Apr 202311:41 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSNotice of GM
30th Mar 202312:24 pmRNSHolding(s) in Company
24th Mar 202310:46 amRNSHolding(s) in Company
23rd Mar 202310:38 amRNSHolding(s) in Company
17th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20232:00 pmRNSHolding(s) in Company
22nd Feb 20231:03 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSDirectorate Change
20th Jan 20237:00 amRNSStatement re Kenya and India
6th Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 202312:14 pmRNSBlock listing Interim Review
2nd Dec 20224:42 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.